Understanding Administration Route Impact
Peptide administration routes significantly affect bioavailability, onset time, and research outcomes. Each route offers distinct advantages depending on peptide characteristics and research objectives.
Subcutaneous Administration
Best For: Most research peptides (BPC-157, TB-500, growth hormone peptides)
Advantages:
- High bioavailability (80-100%)
- Sustained absorption
- Easy self-administration
- Lower infection risk than IV
Considerations: Slower onset than IV, potential injection site reactions
Intramuscular Administration
Best For: Larger peptides, depot formulations
Advantages:
- Rapid absorption
- Suitable for larger volumes
- Good for oil-based solutions
Considerations: More painful, requires proper technique
Oral Administration
Best For: Acid-stable peptides (AOD-9604, some BPC-157 formulations)
Advantages:
- Non-invasive
- Patient compliance
- No injection supplies needed
Limitations: Low bioavailability (typically 1-20%), gastric degradation
Intranasal Administration
Best For: Small, lipophilic peptides targeting CNS
Advantages:
- Bypasses first-pass metabolism
- Direct CNS access
- Rapid absorption
Applications: Cognitive peptides, some neuropeptides
Topical Administration
Best For: Cosmetic peptides (GHK-Cu, AHK-Cu)
Advantages:
- Localized effects
- Minimal systemic exposure
- Non-invasive
Limitations: Limited penetration, variable absorption
Selection Criteria
- Peptide stability in chosen route
- Research objectives (systemic vs. local)
- Bioavailability requirements
- Practical considerations (equipment, expertise)
- Subject tolerance
This information is for research purposes only. Route selection should align with established protocols and institutional guidelines.